A crucial decision is on the horizon, one that could have a significant impact on the health of US children. The future of the hepatitis B vaccine recommendation hangs in the balance.
On Friday, a group of advisers to Robert F. Kennedy Jr., a well-known anti-vaccine advocate, will gather to vote on a controversial proposal. The proposal suggests removing the longstanding recommendation for the hepatitis B vaccine for most American children, a move that has sparked intense debate.
This vote, initially scheduled for Thursday, was delayed due to a chaotic day filled with presentations, some of which questioned the safety of the current US birth dose policy.
Since 1991, the US has strongly recommended the hepatitis B vaccine for all children, with a dose given shortly after birth. This practice has been proven to reduce infection rates by an impressive 95%, according to studies. However, the proposal up for vote suggests a significant change.
Public health experts are concerned that removing the universal recommendation for the birth dose could lead to children developing lifelong hepatitis B infections, which may result in liver cancer and even death. Kennedy, who founded the anti-vaccine organization Children's Health Defense, has taken a bold step by replacing the previous independent experts on the CDC's vaccine advisory committee with individuals who largely share his views.
The committee is expected to consider three proposals. One of these suggests that only infants born to mothers who test positive for hepatitis B should receive the vaccine. For most other children, the decision to vaccinate and the timing would be left to parents and healthcare providers.
The proposal also advises that parents who choose to delay vaccination should not offer the first dose before the child is two months old. Additionally, the committee will vote on whether to test children for hepatitis B antibodies before administering subsequent shots and whether to continue vaccinating infants whose mother's hepatitis B status is unknown.
Dr. Yvonne Maldonado, the Taube Endowed Professor of Global Health and Infectious Diseases at Stanford University School of Medicine, expressed concerns about the potential challenges of implementing shared clinical decision-making. She believes it could lead to missed opportunities for vaccinating infants.
The vaccine manufacturers, including Sanofi, Merck, and GSK, have defended their products, stating that they are safe. However, the discussion on the US vaccination schedule continues.
The final day of the CDC's Advisory Committee on Immunization Practices meeting will feature presentations comparing the US child and adolescent immunization schedule with those of other developed nations. Notably, Aaron Siri, a lawyer and leading anti-vaccine activist, will address the panel on this topic. His presence at such a meeting is unusual, as non-scientists rarely present at these events.
U.S. Senator Bill Cassidy of Louisiana, a Republican and physician who chairs the Senate's Health, Education, Labor, & Pensions Committee, expressed his concerns on X, stating, "Siri is a trial attorney who makes his living suing vaccine manufacturers. He is presenting as if an expert on childhood vaccines."
Senator Cassidy further added, "The ACIP is totally discredited. They are not protecting children."
The immunization schedule, developed by the committee and approved by the CDC, is a crucial guide for parents and healthcare providers, outlining the recommended vaccinations and the appropriate ages for children up to 18 years old.
Tracy Beth Hoeg, an FDA official, will present a comparison of the US vaccine schedule with Denmark's. Additionally, the committee will review the safety of aluminum adjuvants, which are used in vaccines to enhance immunity, focusing on the potential link between aluminum exposure and asthma.
According to the CDC's website, aluminum salts have been used safely in vaccines for over 70 years, initially introduced in the 1930s, 1940s, and 1950s with diphtheria and tetanus shots.
This decision by Kennedy's advisers has the potential to spark a heated debate. What are your thoughts on the matter? Should the hepatitis B vaccine recommendation be dropped for most US children? Share your opinions in the comments below!
